Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05936996 · ClinicalTrials.gov registry record
Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
A clinical trial, sponsored by Essential Medical.
- Completed
- Registry status
- 258
- Enrollment target
NCT05936996 is a clinical trial that has completed, run by Essential Medical. The registered enrollment target is 258 participants.
The verdict
NCT05936996 has completed, sponsored by Essential Medical.
- COMPLETED
- Registry status
- 258 participants
- Enrollment target
Study Summary
This is an observational study designed to evaluate the safety and clinical outcomes of the MANTA® Vascular Closure Device (VCD) (the MANTA® Device) in TAVR procedures. The study will enroll participants who are undergoing a TAVR procedure. The purpose of this study is to examine and collect data on outcomes of contemporary MANTA® large bore closure in standard of care (SOC) TAVR procedures with on-label use of the MANTA® device including appropriate patient selection and proper vascular access.
Interventions
- DEVICE MANTA Vascular Closure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2025-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05936996
The ClinicalTrials.gov registry entry for NCT05936996 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essential Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MANTA Vascular Closure Device is the first listed.
NCT05936996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05936996 about?
NCT05936996 is a clinical study titled "Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes". This is an observational study designed to evaluate the safety and clinical outcomes of the MANTA® Vascular Closure Device (VCD) (the MANTA® Device) in TAVR procedures. The study will enroll participants who are undergoing a TAVR procedure. The purpose of this study is to examine and collect data on...
What is the current status of trial NCT05936996?
This trial is currently completed. The enrollment target is 258 participants. The study started on 2023-11-15. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT05936996?
The interventions under investigation include: MANTA Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT05936996?
This trial is sponsored by Essential Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.